| Source NDC Code |
|
Target HCPCS Code |
00409-1703-01
BORTEZOMIB 2.5 MG VIAL
|
⇄
|
J9044
Injection, bortezomib, not otherwise specified, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
06/09/2022 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IJ |
| Billing Units |
EA |
|
|
|
00409-1703-01
BORTEZOMIB 2.5 MG VIAL
|
⇄
|
J9049
Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
01/01/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IJ |
| Billing Units |
EA |
|
|
|
00409-1703-01
Bortezomib
|
⇄
|
J9049
Inj, bortezomib, hospira
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|